Evidence map›Paper›PMID 35608374›Full record

ArticleJornal brasileiro de nefrologia

Hypothalamic-pituitary-gonadal axis disturbance and its association with insulin resistance in kidney transplant recipients.

Lourdes Balcázar-Hernández, Victoria Mendoza-Zubieta, Baldomero González-Virla, Brenda González-García, Mariana Osorio-Olvera, Jesús Ubaldo Peñaloza-Juarez, Irene Irisson-Mora, Martha Cruz-López, Raúl Rodríguez-Gómez, Ramón Espinoza-Pérez and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Jornal brasileiro de nefrologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Lourdes Balcázar-HernándezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Endocrinology Department, México City, Mexico.ORCID http://orcid.org/0000-0002-0373-6641
Victoria Mendoza-ZubietaInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Endocrinology Department, México City, Mexico.ORCID http://orcid.org/0000-0002-5394-9856
Baldomero González-VirlaInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Endocrinology Department, México City, Mexico.ORCID http://orcid.org/0000-0001-6924-2209
Brenda González-GarcíaUniversidad Nacional Autónoma de México, Facultad de Medicina, Mexico City, Mexico.ORCID http://orcid.org/0000-0001-8911-9320
Mariana Osorio-OlveraUniversidad Nacional Autónoma de México, Facultad de Medicina, Mexico City, Mexico.ORCID http://orcid.org/0000-0003-4127-7308
Jesús Ubaldo Peñaloza-JuarezUniversidad Nacional Autónoma de México, Facultad de Medicina, Mexico City, Mexico.ORCID http://orcid.org/0000-0001-7573-2220
Irene Irisson-MoraInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Endocrinology Department, México City, Mexico.ORCID http://orcid.org/0000-0001-9523-4624
Martha Cruz-LópezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Kidney Transplant Unit, México City, Mexico.ORCID http://orcid.org/0000-0002-0051-4381
Raúl Rodríguez-GómezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Kidney Transplant Unit, México City, Mexico.ORCID http://orcid.org/0000-0001-7773-721X
Ramón Espinoza-PérezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Kidney Transplant Unit, México City, Mexico.ORCID http://orcid.org/0000-0002-1807-736X
Guadalupe Vargas-OrtegaInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Endocrinology Department, México City, Mexico.ORCID http://orcid.org/0000-0002-2225-2925
Mexican Social Security Institute · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate hypothalamic-pi- tuitary-gonadal (HPG) axis alterations at 1 and 12 months after kidney transplan- tation (KT) and their association with in- sulin resistance.

methodsA retrospective clinical study was conducted in a tertiary care center in kidney transplantation recipients (KTRs) aged 18- 50 years with primary kidney disease and stable renal graft function. LH, FSH, E2/T, and HOMA-IR were assessed at 1 and 12 months after KT.

resultsTwenty-five KTRs were included; 53% were men, and the mean age was 30.6±7.7 years. BMI was 22.3 (20.4-24.6) kg/m2, and 36% had hypogonadism at 1 month vs 8% at 12 months (p=0.001). Re- mission of hypogonadism was observed in all men, while in women, hypogonadotropic hypogonadism persisted in two KTRs at 12 months. A positive correlation between go- nadotrophins and age at 1 and 12 months was evident. Fifty-six percent of patients had insulin resistance (IR) at 1 month and 36% at 12 months (p=0.256). HOMA-IR showed a negative correlation with E2 (r=- 0.60; p=0.050) and T (r=-0.709; p=0.049) at 1 month, with no correlation at 12 months. HOMA-IR at 12 months after KT correlated positively with BMI (r=0.52; p=0.011) and tacrolimus dose (r=0.53; p=0.016).

conclusionSuccessful KT restores the HPG axis in the first year. Hypogonadism had a negative correlation with IR in the early pe- riod after KT, but it was not significant at 12 months.

Indexed as

HypogonadismInsulin ResistanceKidney TransplantationAdultFemaleHumansHypothalamic-Pituitary-Gonadal AxisMaleRetrospective StudiesYoung Adult

Identifiers

PMID35608374
PMCPMC10139721
OpenAlexW4281709016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.